Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5464)
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
19,833
Price
$25.50
Total Value
$505.71K
Shares Held After
721,306
% of Holdings
2.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
3,675
Price
$25.50
Total Value
$93.71K
Shares Held After
90,445
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
124,998
Price
$18.44
Total Value
$2.30M
Shares Held After
2,459,245
% of Holdings
4.8%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
337
Price
$16.42
Total Value
$5.53K
Shares Held After
9,970
% of Holdings
3.3%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
830
Price
$45.00
Total Value
$37.35K
Shares Held After
12,546
% of Holdings
6.2%
Allogene Therapeutics, Inc. (ALLO)
Parker Geoffrey M. — CHIEF FINANCIAL OFFICER
Shares
24,001
Price
$1.76
Total Value
$42.24K
Shares Held After
1,252,795
% of Holdings
1.9%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
95,269
Price
$1.80
Total Value
$171.48K
Shares Held After
5,185,862
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$197.19
Total Value
$4.54K
Shares Held After
43,187
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
381
Price
$196.36
Total Value
$74.81K
Shares Held After
43,210
% of Holdings
0.9%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$195.60
Total Value
$4.50K
Shares Held After
43,591
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$192.18
Total Value
$192.18
Shares Held After
43,614
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
39
Price
$191.00
Total Value
$7.45K
Shares Held After
43,615
% of Holdings
0.1%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
7,549
Price
$1.73
Total Value
$13.06K
Shares Held After
210,172
% of Holdings
3.5%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
736
Price
$46.63
Total Value
$34.32K
Shares Held After
12,965
% of Holdings
5.4%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
4,064
Price
$46.03
Total Value
$187.07K
Shares Held After
13,701
% of Holdings
22.9%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
200
Price
$44.15
Total Value
$8.83K
Shares Held After
17,765
% of Holdings
1.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
Invus Global Management, LLC — Director
Shares
1,538,462
Price
$1.30
Total Value
$2.00M
Shares Held After
1,538,462
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
100
Price
$47.23
Total Value
$4.72K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,936
Price
$46.37
Total Value
$275.27K
Shares Held After
100
% of Holdings
98.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
8,364
Price
$45.89
Total Value
$383.82K
Shares Held After
6,036
% of Holdings
58.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
600
Price
$44.20
Total Value
$26.52K
Shares Held After
14,400
% of Holdings
4.0%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
20,070
Price
$5.09
Total Value
$102.17K
Shares Held After
137,722
% of Holdings
12.7%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
370
Price
$59.41
Total Value
$21.98K
Shares Held After
26,051
% of Holdings
1.4%
Absci Corp (ABSI)
Jonasson Zachariah — CFO / CBO
Shares
17,496
Price
$2.99
Total Value
$52.31K
Shares Held After
383,538
% of Holdings
4.4%
Absci Corp (ABSI)
McClain Sean — Director
Shares
26,761
Price
$2.99
Total Value
$80.02K
Shares Held After
8,334,567
% of Holdings
0.3%
ENSIGN GROUP, INC (ENSG)
SMITH BARRY M — Director
Shares
700
Price
$171.54
Total Value
$120.08K
Shares Held After
23,552
% of Holdings
2.9%
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
35,700
Price
$1.77
Total Value
$63.19K
Shares Held After
581,166
% of Holdings
5.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
5,843
Price
$42.08
Total Value
$245.90K
Shares Held After
30,167
% of Holdings
16.2%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
102,581
Price
$42.08
Total Value
$4.32M
Shares Held After
292,415
% of Holdings
26.0%
Allogene Therapeutics, Inc. (ALLO)
Yoshiyama Annie — SVP, Finance
Shares
4,167
Price
$1.72
Total Value
$7.17K
Shares Held After
130,322
% of Holdings
3.1%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
22,900
Price
$1.76
Total Value
$40.30K
Shares Held After
564,948
% of Holdings
3.9%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$20.54
Total Value
$135.87K
Shares Held After
167,617
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
3,025
Price
$20.57
Total Value
$62.22K
Shares Held After
167,617
% of Holdings
1.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$20.57
Total Value
$30.28K
Shares Held After
167,617
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
15,500
Price
$14.69
Total Value
$227.62K
Shares Held After
3,363,898
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
3,448
Price
$14.65
Total Value
$50.52K
Shares Held After
144,693
% of Holdings
2.3%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
15,500
Price
$14.68
Total Value
$227.59K
Shares Held After
3,363,965
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
3,557
Price
$14.65
Total Value
$52.10K
Shares Held After
173,547
% of Holdings
2.0%
REVVITY, INC. (RVTY)
Vohra Tajinder S — Senior Vice President, Global Operations
Shares
5,756
Price
$104.50
Total Value
$601.50K
Shares Held After
10,442
% of Holdings
35.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
100
Price
$58.00
Total Value
$5.80K
Shares Held After
450,944
% of Holdings
0.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
16,463
Price
$83.03
Total Value
$1.37M
Shares Held After
80,293
% of Holdings
17.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
48,626
Price
$83.03
Total Value
$4.04M
Shares Held After
80,293
% of Holdings
37.7%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
20,000
Price
$82.60
Total Value
$1.65M
Shares Held After
80,293
% of Holdings
19.9%
Fulcrum Therapeutics, Inc. (FULC)
Gould Robert J — Director
Shares
15,000
Price
$10.72
Total Value
$160.86K
Shares Held After
454,864
% of Holdings
3.2%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
83,689
Price
$1.39
Total Value
$116.33K
Shares Held After
3,297,794
% of Holdings
2.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
114,891
Price
$1.39
Total Value
$159.70K
Shares Held After
3,206,233
% of Holdings
3.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
96,065
Price
$1.39
Total Value
$133.53K
Shares Held After
3,321,124
% of Holdings
2.8%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
46,660
Price
$1.39
Total Value
$64.86K
Shares Held After
3,417,189
% of Holdings
1.3%
Doximity, Inc. (DOCS)
Wampler Kira Scherer — Director
Shares
2,000
Price
$37.33
Total Value
$74.66K
Shares Held After
19,839
% of Holdings
9.2%
Showing 3301–3350 of 5464 transactions (page 67 of 110)